FOXC2 was previously termed Mesenchyme Forkhead 1 (MFH-1), and recently has been identified as an essential mediator of the epithelial-mesenchymal transition (EMT) process [36–38] that is mainly activated during tumor metastasis and progression [39–40]. Here, FOXC2 is linked to neoplasm.